Papers by John Budde · AgingResearch.News

The Lancet Neurology24 Sep
Dynamic changes in plasma biomarkers of Alzheimer's disease in patients treated with lecanemab: a longitudinal cohort study
Study in peopleInterventions
Paper
Alzheimer's & Dementia14 Aug
A plasma-based protein signature combining NPTXR, ACHE, and p-tau217 predicts progression to symptomatic Alzheimer's disease
Cohort study in peopleAlzheimer's disease
Paper
AAIC 2025 Abstract25 Dec
Sex‐specific genetic regulation of proteomics in cerebrospinal fluid uncovers genetic causes for sex differences in AD and PD
Study in peopleMechanisms
Paper
AAIC 2025 Abstract25 Dec
Novel early‐onset Alzheimer‐associated genes influence risk through dysregulation of glutamate, immune activation, and intracell signaling pathways
Study in peopleMechanisms
Paper

AAIC 2025 Abstract24 Dec
Identification of genetic modifiers influencing disease risk in autosomal dominant Alzheimer disease mutation carriers
Study in peoplePopulations
Paper
AAIC 2025 Abstract24 Dec
Sex‐stratified GWAS meta‐analyses reveal novel sex‐specific association with CSF biomarkers of Alzheimer's Disease
Study in peopleBiomarkers
Paper
AAIC 2025 Abstract23 Dec
Sex‐specific genetic regulation of proteomics in cerebrospinal fluid uncovers genetic causes for sex differences in AD and PD
Study in peopleMechanisms
Paper